These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 32888021)

  • 1. A Prospective Study of Children Aged 0-8 Years with CAH and Adrenal Insufficiency Treated with Hydrocortisone Granules.
    Neumann U; Braune K; Whitaker MJ; Wiegand S; Krude H; Porter J; Digweed D; Voet B; Ross RJM; Blankenstein O
    J Clin Endocrinol Metab; 2021 Mar; 106(3):e1433-e1440. PubMed ID: 32888021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucocorticoid replacement regimens for treating congenital adrenal hyperplasia.
    Ng SM; Stepien KM; Krishan A
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD012517. PubMed ID: 32190901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scalp hair 17-hydroxyprogesterone and androstenedione as a long-term therapy monitoring tool in congenital adrenal hyperplasia.
    Noppe G; de Rijke YB; Koper JW; van Rossum EF; van den Akker EL
    Clin Endocrinol (Oxf); 2016 Oct; 85(4):522-7. PubMed ID: 27061431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paediatric population pharmacokinetic modelling to assess hydrocortisone replacement dosing regimens in young children.
    Michelet R; Melin J; Parra-Guillen ZP; Neumann U; Whitaker JM; Stachanow V; Huisinga W; Porter J; Blankenstein O; Ross RJ; Kloft C
    Eur J Endocrinol; 2020 Oct; 183(4):357-368. PubMed ID: 32621587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variations in the management of acute illness in children with congenital adrenal hyperplasia: An audit of three paediatric hospitals.
    Chrisp GL; Maguire AM; Quartararo M; Falhammar H; King BR; Munns CF; Torpy DJ; Hameed S; Rushworth RL
    Clin Endocrinol (Oxf); 2018 Nov; 89(5):577-585. PubMed ID: 30086199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal Assessment of Illnesses, Stress Dosing, and Illness Sequelae in Patients With Congenital Adrenal Hyperplasia.
    El-Maouche D; Hargreaves CJ; Sinaii N; Mallappa A; Veeraraghavan P; Merke DP
    J Clin Endocrinol Metab; 2018 Jun; 103(6):2336-2345. PubMed ID: 29584889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of Acute Adrenal Insufficiency-Related Adverse Events in Children with Congenital Adrenal Hyperplasia: Results of an International Survey of Specialist Centres.
    Ali SR; Bryce J; Krone NP; Claahsen-van der Grinten HL; Ahmed SF
    Horm Res Paediatr; 2022; 95(4):363-373. PubMed ID: 35569445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between androstenedione and 17-hydroxyprogesterone levels in the saliva and plasma of patients with congenital adrenal hyperplasia.
    Juniarto AZ; Goossens K; Setyawati BA; Drop SL; de Jong FH; Faradz SM
    Singapore Med J; 2011 Nov; 52(11):810-3. PubMed ID: 22173250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic/Pharmacodynamic Evaluation of Hydrocortisone Therapy in Pediatric Patients with Congenital Adrenal Hyperplasia.
    Melin J; Parra-Guillen ZP; Michelet R; Truong T; Huisinga W; Hartung N; Hindmarsh P; Kloft C
    J Clin Endocrinol Metab; 2020 Mar; 105(3):. PubMed ID: 32052005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prednisolone in the treatment of adrenal insufficiency: a re-evaluation of relative potency.
    Punthakee Z; Legault L; Polychronakos C
    J Pediatr; 2003 Sep; 143(3):402-5. PubMed ID: 14517528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Völkl TM; Simm D; Beier C; Dörr HG
    Pediatrics; 2006 Jan; 117(1):e98-105. PubMed ID: 16396852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reverse circadian glucocorticoid treatment in prepubertal children with congenital adrenal hyperplasia.
    Dubinski I; Bechtold Dalla-Pozza S; Bidlingmaier M; Reisch N; Schmidt H
    J Pediatr Endocrinol Metab; 2021 Dec; 34(12):1543-1548. PubMed ID: 34523293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Phase 2, Multicenter Study of Nevanimibe for the Treatment of Congenital Adrenal Hyperplasia.
    El-Maouche D; Merke DP; Vogiatzi MG; Chang AY; Turcu AF; Joyal EG; Lin VH; Weintraub L; Plaunt MR; Mohideen P; Auchus RJ
    J Clin Endocrinol Metab; 2020 Aug; 105(8):2771-8. PubMed ID: 32589738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term prednisone versus hydrocortisone treatment in children with classic Congenital Adrenal Hyperplasia (CAH) and a brief review of the literature.
    Ahmed SEAM; Soliman AT; Ramadan MA; Elawwa A; Abugabal AMS; Emam MHA; De Sanctis V
    Acta Biomed; 2019 Sep; 90(3):360-369. PubMed ID: 31580328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circadian hydrocortisone infusions in patients with adrenal insufficiency and congenital adrenal hyperplasia.
    Merza Z; Rostami-Hodjegan A; Memmott A; Doane A; Ibbotson V; Newell-Price J; Tucker GT; Ross RJ
    Clin Endocrinol (Oxf); 2006 Jul; 65(1):45-50. PubMed ID: 16817818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Congenital Adrenal Hyperplasia in Children: A Pilot Study of Steroid Hormones Expressed as Sex- and Age-Related Standard Deviation Scores.
    Clausen CS; Ljubicic ML; Main KM; Andersson AM; Petersen JH; Frederiksen H; Duno M; Johannsen TH; Juul A
    Horm Res Paediatr; 2020; 93(4):226-238. PubMed ID: 33017824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. European Adrenal Insufficiency Registry (EU-AIR): a comparative observational study of glucocorticoid replacement therapy.
    Ekman B; Fitts D; Marelli C; Murray RD; Quinkler M; Zelissen PM
    BMC Endocr Disord; 2014 May; 14():40. PubMed ID: 24884782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experience with long-term glucocorticoid treatment in congenital adrenal hyperplasia: growth pattern compared with genetic height potential.
    Aycan Z; Ocal G; Berberoglu M; Cetinkaya E; Adiyaman P; Evliyaoglu O
    J Pediatr Endocrinol Metab; 2006 Mar; 19(3):245-51. PubMed ID: 16607925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control in congenital adrenal hyperplasia monitored by frequent saliva 17OH-progesterone measurements.
    Hughes IA; Read GF
    Horm Res; 1984; 19(2):77-85. PubMed ID: 6538545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HYDROCORTISONE THERAPY AND GROWTH TRAJECTORY IN CHILDREN WITH CLASSICAL CONGENITAL ADRENAL HYPERPLASIA.
    Bizzarri C; Improda N; Maggioli C; Capalbo D; Roma S; Porzio O; Salerno M; Cappa M
    Endocr Pract; 2017 May; 23(5):546-556. PubMed ID: 28225306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.